In that mouse model, LKB1 is one of the major downstream targets and uncoupling of the LKB1-AMPK pathway by oncogenic BRAF is one possible mechanism to promote the proliferation of melanoma cells with BRAF mutations [86]. Here, PRKAA2 is linked to melanoma.